MONTREAL, QUEBEC--(Marketwire - February 28, 2008) - Ambrilia Biopharma Inc. (TSX: AMB) has announced today the departure of Dr. Chandra J. Panchal as Executive Vice-President, Business Development, Licensing and Intellectual Property, effective March 1, 2008. Dr. Panchal will continue to serve as Senior Adviser to the President and CEO, on a per project basis, until December 31, 2008.
